Cancer Research Meeting Calendar Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Cancer Research 67, 6477, July 1, 2007. doi: 10.1158/0008-5472.CAN-07-0746
© 2007 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eeckhoute, J.
Right arrow Articles by Brown, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eeckhoute, J.
Right arrow Articles by Brown, M.

Endocrinology

Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor {alpha} Expression in Breast Cancer

Jérôme Eeckhoute, Erika Krasnickas Keeton, Mathieu Lupien, Susan A. Krum, Jason S. Carroll and Myles Brown

Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Myles Brown, Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA 02115. Phone: 617-632-4738; Fax: 617-582-8501; E-mail: myles_brown{at}dfci.harvard.edu.

The transcription factor GATA-3 is required for normal mammary gland development, and its expression is highly correlated with estrogen receptor {alpha} (ER{alpha}) in human breast tumors. However, the functional role of GATA-3 in ER{alpha}-positive breast cancers is yet to be established. Here, we show that GATA-3 is required for estradiol stimulation of cell cycle progression in breast cancer cells. The role of GATA-3 in estradiol signaling requires the direct positive regulation of the expression of the ER{alpha} gene itself by GATA-3. GATA-3 binds to two cis-regulatory elements located within the ER{alpha} gene, and this is required for RNA polymerase II recruitment to ER{alpha} promoters. Reciprocally, ER{alpha} directly stimulates the transcription of the GATA-3 gene, indicating that these two factors are involved in a positive cross-regulatory loop. Moreover, GATA-3 and ER{alpha} regulate their own expression in breast cancer cells. Hence, this transcriptional coregulatory mechanism accounts for the robust coexpression of GATA-3 and ER{alpha} in human breast cancers. In addition, these results highlight the crucial role of GATA-3 for the response of ER{alpha}-positive breast cancers to estradiol. Moreover, they identify GATA-3 as a critical component of the master cell-type–specific transcriptional network including ER{alpha} and FoxA1 that dictates the phenotype of hormone-dependent breast cancer. [Cancer Res 2007;67(13):6477–83]




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
S. J. Ellison-Zelski, N. M. Solodin, and E. T. Alarid
Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter
Mol. Cell. Biol., September 15, 2009; 29(18): 4949 - 4958.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. D. Adams, D. M. Cowee, and B. A. White
The Role of miR-206 in the Epidermal Growth Factor (EGF) Induced Repression of Estrogen Receptor-{alpha} (ER{alpha}) Signaling and a Luminal Phenotype in MCF-7 Breast Cancer Cells
Mol. Endocrinol., August 1, 2009; 23(8): 1215 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. Bhat-Nakshatri, G. Wang, N. R. Collins, M. J. Thomson, T. R. Geistlinger, J. S. Carroll, M. Brown, S. Hammond, E. F. Srour, Y. Liu, et al.
Estradiol-regulated microRNAs control estradiol response in breast cancer cells
Nucleic Acids Res., August 1, 2009; 37(14): 4850 - 4861.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Lupien, J. Eeckhoute, C. A. Meyer, S. A. Krum, D. R. Rhodes, X. S. Liu, and M. Brown
Coactivator Function Defines the Active Estrogen Receptor Alpha Cistrome
Mol. Cell. Biol., June 15, 2009; 29(12): 3413 - 3423.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Stanisic, A. Malovannaya, J. Qin, D. M. Lonard, and B. W. O'Malley
OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) {alpha} and Affects ER{alpha} Transcriptional Activity
J. Biol. Chem., June 12, 2009; 284(24): 16135 - 16145.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M. Lupien and M. Brown
Cistromics of hormone-dependent cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 381 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Nucera, J. Eeckhoute, S. Finn, J. S. Carroll, A. H. Ligon, C. Priolo, G. Fadda, M. Toner, O. Sheils, M. Attard, et al.
FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma
Clin. Cancer Res., June 1, 2009; 15(11): 3680 - 3689.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. H. Shirley, J. E. Rundhaug, J. Tian, N. Cullinan-Ammann, I. Lambertz, C. J. Conti, and R. Fuchs-Young
Transcriptional Regulation of Estrogen Receptor-{alpha} by p53 in Human Breast Cancer Cells
Cancer Res., April 15, 2009; 69(8): 3405 - 3414.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Mercier, M. C. Casimiro, J. Zhou, C. Wang, C. Plymire, K. G. Bryant, K. M. Daumer, F. Sotgia, G. Bonuccelli, A. K. Witkiewicz, et al.
Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions
Am. J. Pathol., April 1, 2009; 174(4): 1172 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
J. Eeckhoute, M. Lupien, C. A. Meyer, M. P. Verzi, R. A. Shivdasani, X. S. Liu, and M. Brown
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Genome Res., March 1, 2009; 19(3): 372 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Magklara and C. L. Smith
A Composite Intronic Element Directs Dynamic Binding of the Progesterone Receptor and GATA-2
Mol. Endocrinol., January 1, 2009; 23(1): 61 - 73.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. N. Sundar, C. N. Marconett, V. B. Doan, J. A. Willoughby Sr, and G. L. Firestone
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells
Carcinogenesis, December 1, 2008; 29(12): 2252 - 2258.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
M.-L. Asselin-Labat, F. Vaillant, M. Shackleton, T. Bouras, G.J. Lindeman, and J.E. Visvader
Delineating the Epithelial Hierarchy in the Mouse Mammary Gland
Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.020v2.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
K. A. Holmes, J. S. Song, X. S. Liu, M. Brown, and J. S. Carroll
Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity
Cancer Res., September 15, 2008; 68(18): 7380 - 7385.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. L. LaMarca and J. M. Rosen
Hormones and Mammary Cell Fate--What Will I Become When I Grow Up?
Endocrinology, September 1, 2008; 149(9): 4317 - 4321.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X. Leleu, J. Eeckhoute, X. Jia, A. M. Roccaro, A.-S. Moreau, M. Farag, A. Sacco, H. T. Ngo, J. Runnels, M. R. Melhem, et al.
Targeting NF-{kappa}B in Waldenstrom macroglobulinemia
Blood, May 15, 2008; 111(10): 5068 - 5077.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M A Thorat, C Marchio, A Morimiya, K Savage, H Nakshatri, J S Reis-Filho, and S Badve
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
J. Clin. Pathol., March 1, 2008; 61(3): 327 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Germaniuk-Kurowska, A. Nag, X. Zhao, M. Dimri, H. Band, and V. Band
Ada3 Requirement for HAT Recruitment to Estrogen Receptors and Estrogen-Dependent Breast Cancer Cell Proliferation
Cancer Res., December 15, 2007; 67(24): 11789 - 11797.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.